{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T12:24:32Z","timestamp":1746707072136,"version":"3.40.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Soonchunhyang University Research Fund","award":["no"],"award-info":[{"award-number":["no"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Neuromyelitis optica spectrum disorder (NMOSD) is a severe inflammatory disorder of the central nervous system with an autoantibody against aquaporin-4 protein (AQP4), and amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. We report a female patient with ALS who had asymptomatic AQP4 antibody at the diagnosis of ALS, and NMOSD occurred 4\u200ayears later after the diagnosis of ALS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>She was already bedridden and had tracheostomy because of ALS which was diagnosed at her age of 55. At the time of her ALS diagnosis, she had no brain or spinal cord lesions, but was seropositive for AQP4 antibody. At her age of 59, new-onset complete paralysis of all extremities and severe pain on the posterior neck and both shoulders occurred and visited the hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Longitudinally extensive transverse myelitis was diagnosed, which was the onset attack of seropositive NMOSD. The diagnosis was confirmed based on the international consensus diagnostic criteria for NMOSD with MR imaging, cerebrospinal fluid exam and laboratory work-ups with AQP4 antibody test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>High dose methylprednisolone was administered for 5\u200adays. Plasma exchange as a further treatment was recommended, but she and her family refused.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Her pain was relieved after steroid treatment, but there was no improvement of her leg weakness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case is a rare combination of neuroinflammatory and neurodegenerative diseases. Considering the alterations of blood-brain barrier along with the progression of ALS, it highlights that the consequence of ALS pathogenesis might affect the development of NMOSD. And the careful follow-up is recommended even in patients with profound weakness, especially if those who were at risk of developing certain neurological disorders.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025580","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T13:19:26Z","timestamp":1619011166000},"page":"e25580","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Sporadic amyotrophic lateral sclerosis with seropositive neuromyelitis optica spectrum disorder"],"prefix":"10.1097","volume":"100","author":[{"given":"Jin Young","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Soonchunhyang University Hospital Bucheon, Soonchunhyang University College of Medicine, Bucheon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jeong","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Soonchunhyang University Hospital Cheonan, Soonchunhyang University College of Medicine, Cheonan, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Myoung","family":"Seok","sequence":"additional","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WCO.0000000000000551","article-title":"Mechanisms for lesion localization in neuromyelitis optica spectrum disorders","volume":"31","author":"Bradl","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","article-title":"A case of NMO seropositive for aquaporin-4 antibody more than 10\u200ayears before onset","volume":"72","author":"Nishiyama","year":"2009","journal-title":"Neurology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","article-title":"Impaired blood-brain\/spinal cord barrier in ALS patients","volume":"1469","author":"Garbuzova-Davis","year":"2012","journal-title":"Brain Res"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2018-318974","article-title":"Epidemiology of ALS in Korea using nationwide big data","volume":"90","author":"Jun","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1177\/1352458519888609","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea","volume":"26","author":"Kim","year":"2019","journal-title":"Mult Scler"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/21678421.2019.1604761","article-title":"Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72","volume":"20","author":"Falzone","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1941874418783914","article-title":"Coexistence of neuromyelitis optica and amyotrophic lateral sclerosis: a case report","volume":"9","author":"Li","year":"2019","journal-title":"Neurohospitalist"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1352458511401945","article-title":"First attack of Devic's neuromyelitis optica following endovascular treatment and rupture of brain arteriovenous malformation","volume":"17","author":"Ritzenthaler","year":"2011","journal-title":"Mult Scler"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","article-title":"Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis","volume":"7","author":"Ferraiuolo","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1212\/WNL.0b013e3182a6cc13","article-title":"Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study","volume":"81","author":"Turner","year":"2013","journal-title":"Neurology"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1038\/srep23204","article-title":"C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice","volume":"6","author":"Atanasio","year":"2016","journal-title":"Sci Rep"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1311.e7","DOI":"10.1016\/j.neurobiolaging.2012.09.004","article-title":"Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis","volume":"34","author":"Jang","year":"2013","journal-title":"Neurobiol Aging"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:10:55Z","timestamp":1746339055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025580"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":16,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025580","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"2021-01-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}